FLGT — Fulgent Genetics Share News
0.000.00%
Last trade - 00:00- $587.18m
- $328.54m
- $322.67m
Fulgent Genetics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Fulgent Reports Third Quarter 2024 Financial Results
Brief: Fulgent Genetics Q3 Revenue USD 71.743 Million
Brief: Fulgent Genetics Awarded Contract By The U.S. Department Of Veterans Affairs To Provide Hereditary Cancer, Pharmacogenetic And Other Genetic Testing To Veterans1
Brief: Fulgent Genetics Q2 Revenue USD 71.028 Million
Fulgent Genetics Inc expected to post a loss of 30 cents a share - Earnings Preview
Fulgent Genetics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Fulgent Genetics Q1 Revenue USD 64.485 Million
Fulgent Genetics Inc expected to post a loss of 32 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Arrivent Biopharma, Ferguson, Target
Brief: Fulgent Genetics Q4 Revenue USD 70.505 Million
Fulgent Genetics Inc expected to post a loss of 29 cents a share - Earnings Preview
Fulgent Genetics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Fulgent Genetics Q3 Revenue USD 19 Million
Fulgent Genetics Inc expected to post a loss of 33 cents a share - Earnings Preview
Fulgent Genetics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Fulgent Genetics Q2 Revenue USD 68 Million
Fulgent Genetics Inc expected to post a loss of 33 cents a share - Earnings Preview
Fulgent Genetics Inc reports results for the quarter ended in March - Earnings Summary